Press release
Esoteric Testing Market is expected to garner USD 50.17 billion by 2029 at 11.5% CAGR from 2022 to 2029
The global Esoteric Testing Market is expected to grow at an 11.5 % CAGR from 2022 to 2029. It is expected to reach above USD 50.17 billion by 2029 from USD 18.83 billion in 2020.The ageing population, rising rates of chronic and infectious diseases, the development of esoteric DNA sequencing technologies for precision medicine, and early cancer diagnosis and precision medicine all contribute to the Esoteric Testing Market expansion.
Esoteric test technology is improving, allowing for faster results with improved efficacy, detection limits, and sensitivity. The growing use of esoteric DNA sequencing, NGS technologies, and whole-genome sequencing in cancer early detection, precision medicine, and personalized medicine is further propelling the market forward.
Get Sample with Latest Trends and Future Advancements at: (Get Higher Priority for Corporate Email ID): https://exactitudeconsultancy.com/reports/10642/esoteric-testing-market/#request-a-sample?Mode=dailyhealthupdates
Some of the major companies are Labcorp, Quest Diagnostics, OPKO Health Inc., CM Global Laboratories, Laboratory Corporation of America, Fulgent Genetics, Arup Laboratories, Mayo Medical Laboratories, Invitae, Myriad Genetics, Nordic Laboratories, Genomic Health, American Esoteric Laboratories (AEL), Miraca Holdings and BioMONTR, and many more.
Regional Outlook-
North America is dominated to lead largest share in the esoteric testing market due to increase in occurrence of chronic disease and rise in number of diagnostic tests and technological advancement for esoteric testing. Furthermore, Asia-Pacific holds the highest revenue due to high prevalence of chronic disease, surging government initiative for diagnostic service, surge in demand for ELISA and RT-PCR test, and rise in concern among population for self-diagnostic testing.
Market Developments
In 2021, Labcorp has acquired Myriad Genetics' autoimmune business unit.
In 2021, Quest Diagnostics has collaborated with GRAIL to support a first-of-its-kind multi-cancer early detection blood test called Galleri.
Browse Detailed Research Insights with TOC:
https://exactitudeconsultancy.com/reports/10642/esoteric-testing-market/
Key Market Segments: Global Esoteric testing Market
Global Esoteric Testing Market by Type, 2020-2029, (USD Million)
Infectious Disease
Endocrinology
Oncology
Toxicology
Immunology
Genetic Testing
Global Esoteric Testing Market by Technology, 2020-2029, (USD Million)
MS
CLIA
ELISA
PCR
Global Esoteric Testing Market by End User, 2020-2029, (USD Million)
Independent & Reference Laboratories
Hospital Laboratories
Check Discount on This Research: https://exactitudeconsultancy.com/reports/10642/esoteric-testing-market/#inquire-for-discount
The objective of the Study:
To analyze the historical growth in the market size of the global Esoteric Testing from 2017 to 2021.
To estimate and forecast the market size of Esoteric Testing market from 2022 to 2029 and growth rate until 2029.
To classify and forecast the global Esoteric Testing market based on diagnosis type, cancer type, end user, region, and company.
To identify the dominant region or segment in the global Esoteric Testing market.
To identify drivers and challenges for the global Esoteric Testing market.
Thanks for reading this Article.
Connect us on:
You Tube Link- https://www.youtube.com/channel/UCts2fMbshxihDcnv2yRtvBg
Linked In- https://www.linkedin.com/company/exactitudeconsultancy/
Twitter- https://twitter.com/ExactitudeCons
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us: Exactitude Consultancy is a market research & consulting services firm that helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Esoteric Testing Market is expected to garner USD 50.17 billion by 2029 at 11.5% CAGR from 2022 to 2029 here
News-ID: 2715612 • Views: …
More Releases from Exactitude Consultancy
Cell Therapy Manufacturing Market to Reach USD 28.4 Billion by 2034, Growing at …
Introduction
Cell therapy has emerged as a transformative pillar of modern medicine, offering the potential to repair, replace, or regenerate damaged tissues and organs. From CAR-T cell therapies for oncology to stem cell therapies for regenerative medicine, the field is redefining treatment paradigms across oncology, neurology, cardiology, and rare diseases.
As clinical pipelines expand and more therapies achieve regulatory approval, demand for efficient and scalable cell therapy manufacturing has surged. Specialized technologies…
Despite safety concerns, adavosertib exhibits early antitumor activity in uterin …
Uterine serous carcinoma (USC) is a rare but highly aggressive subtype of endometrial cancer, accounting for less than 10% of endometrial cancer cases but contributing to a disproportionately high mortality rate. It is often diagnosed at advanced stages, making it difficult to treat with conventional methods.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72873
In recent years, the treatment landscape has expanded beyond chemotherapy and surgery to include targeted therapies,…
Market for Catheter-Related Bloodstream Infections: Overview, Therapies, and Imp …
Catheter-related bloodstream infections (CRBSIs) are among the most common and serious complications associated with intravascular catheters used in hospitals and long-term care settings. These infections can lead to prolonged hospital stays, increased healthcare costs, and higher mortality rates. With the rising use of central venous catheters, particularly among critically ill patients, oncology cases, and those requiring long-term intravenous therapy, the global demand for effective prevention and treatment solutions is growing…
ADC Technology Market to Reach USD 33.7 Billion by 2034, Growing at 13.2% CAGR
Introduction
Antibody-drug conjugates (ADCs) represent one of the most innovative breakthroughs in oncology, combining the target specificity of monoclonal antibodies with the cytotoxic potency of chemotherapeutic agents. By delivering highly toxic payloads directly to cancer cells, ADCs minimize systemic toxicity and enhance therapeutic efficacy.
As cancer incidence rises worldwide and the limitations of conventional chemotherapy become more evident, ADC technology is gaining momentum. With advancements in linker chemistry, payload design, and next-generation…
More Releases for Esoteric
Esoteric Testing Market Statistics and Growth Prediction 2021- American Esoteric …
The Esoteric Testing market is a comprehensive market research report which provides market analysis with a historical & futuristic perspective for the following parameters; market size, revenue, demand, and supply data (as applicable). The report offers detailed market analysis to provide a 360-degree research study on the global Esoteric Testing market. Some of the tools used for this are SWOT, PESTEL and Porter's 5-forces analysis frameworks. The report includes detailed…
Esoteric testing market Statistical Analysis Report| Top Companies: Genomic Heal …
Increasing incidences of rare and complex diseases coupled with growing awareness about early disease diagnosis and treatment will drive esoteric testing market over the forecast period. According to European Commission, nearly 27 to 36 million people suffer from rare disease in European region.
Rapidly improving healthcare sector in developing countries along with rising number of sophisticated laboratories offering advanced services will favour industry growth. Growing number of baby boomers prone to…
Esoteric testing market Statistical Analysis Report 2019| Top Companies: Genomic …
Global Esoteric Testing Market is set to exceed USD 35 billion by 2024; according to a new research report by Global Market Insights.
Increasing prevalence of chronic diseases and infectious diseases in developing countries such as China along with rising geriatric population, highly susceptible to suffer from chronic disorders will drive esoteric testing market over the forecast timeframe. Rising number of people suffering from rare diseases has escalated burden on…
Esoteric testing market Statistical Analysis Report| Top Companies: Genomic Heal …
Increasing incidences of rare and complex diseases coupled with growing awareness about early disease diagnosis and treatment will drive esoteric testing market over the forecast period. According to European Commission, nearly 27 to 36 million people suffer from rare disease in European region.
Rapidly improving healthcare sector in developing countries along with rising number of sophisticated laboratories offering advanced services will favour industry growth. Growing number of baby boomers prone to…
Esoteric testing market Statistical Analysis Report| Top Companies: Genomic Heal …
Increasing incidences of rare and complex diseases coupled with growing awareness about early disease diagnosis and treatment will drive esoteric testing market over the forecast period. According to European Commission, nearly 27 to 36 million people suffer from rare disease in European region.
Rapidly improving healthcare sector in developing countries along with rising number of sophisticated laboratories offering advanced services will favour industry growth. Growing number of baby boomers prone to…
Esoteric testing market Statistical Analysis Report| Top Companies: Genomic Heal …
Increasing incidences of rare and complex diseases coupled with growing awareness about early disease diagnosis and treatment will drive esoteric testing market over the forecast period. According to European Commission, nearly 27 to 36 million people suffer from rare disease in European region.
Rapidly improving healthcare sector in developing countries along with rising number of sophisticated laboratories offering advanced services will favour industry growth. Growing number of baby boomers prone to…
